SCIA
GILD icon

Sanibel Captiva Investment Advisers’s Gilead Sciences GILD Stock Holding History

Sanibel Captiva Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$790K Sell
10,525
-650
-6% -$45.3K 0.49% 63
2013
Q3 		$703K Buy
+11,175
New +$668K 0.54% 52

Other funds holding GILD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sanibel Captiva Investment Advisers's GILD Position: Q4 2013 in Review

Sanibel Captiva Investment Advisers reduced its Gilead Sciences (GILD) stake by 5.8% in Q4 2013, selling an estimated $45.3K and leaving 10,525 shares worth $790K. The position accounts for 0.49% of the portfolio, ranked #63.

Sanibel Captiva Investment Advisers first reported a position in GILD in Q3 2013 and has held it in 2 quarters since. 1,100 funds tracked by Wall St. Rank hold GILD as of Q4 2013.

  • Sanibel Captiva Investment Advisers held 10,525 shares of Gilead Sciences worth $790K as of Q4 2013.
  • Sanibel Captiva Investment Advisers sold 650 Gilead Sciences shares in Q4 2013, an estimated $45.3K.
  • Gilead Sciences made up 0.49% of Sanibel Captiva Investment Advisers's portfolio in Q4 2013, its #63 holding.
  • Sanibel Captiva Investment Advisers first reported a position in Gilead Sciences in Q3 2013 and has held it in 2 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2013.

Based on Sanibel Captiva Investment Advisers's 13F filing for Q4 2013, filed 18 Feb 2014.